Published in Am J Pathol on August 01, 1994
RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn (2012) 4.63
Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol (1997) 1.73
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69
PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. J Virol (2001) 1.14
Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease. J Clin Pathol (1995) 1.10
Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus. J Virol (1999) 0.98
Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer. Korean J Intern Med (2004) 0.94
Spontaneous splenic rupture in infectious mononucleosis: a review. Yale J Biol Med (1998) 0.93
Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis. Curr Infect Dis Rep (2004) 0.90
Epstein-Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma. Diagn Pathol (2006) 0.90
Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol (1998) 0.85
Anti-Epstein-Barr virus (EBV) activity of beta-L-5-iododioxolane uracil is dependent on EBV thymidine kinase. Antimicrob Agents Chemother (2000) 0.79
Absence of Epstein-Barr virus in oesophageal squamous cell carcinoma. Clin Mol Pathol (1995) 0.78
Pleomorphic adenoma in the nasal cavity: a clinicopathological study of ten cases in Finland. Eur Arch Otorhinolaryngol (2016) 0.77
Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in Pakistan. Diagn Pathol (2011) 0.77
Study of Epstein-Barr virus expression in Burkitt's lymphoma by polymerase chain reaction and in situ hybridization: A study in Iran. Dent Res J (Isfahan) (2014) 0.75
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc (1997) 0.75
Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis. Oncol Lett (2012) 0.75
Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity. Jpn Dent Sci Rev (2017) 0.75
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell (1991) 7.40
Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell (1986) 7.34
Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science (1990) 7.18
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J (1987) 6.26
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell (1986) 5.13
Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet (1991) 4.76
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med (1992) 4.11
Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med (1989) 3.76
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med (1992) 3.75
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol (1990) 3.54
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol (1992) 3.41
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci U S A (1990) 3.29
The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci U S A (1993) 3.22
Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood (1989) 2.95
EBV gene expression in an NPC-related tumour. EMBO J (1989) 2.94
Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci U S A (1986) 2.84
Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A (1991) 2.82
Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol (1987) 2.74
T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med (1988) 2.63
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci U S A (1991) 2.61
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol (1990) 2.60
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol (1991) 2.58
Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med (1993) 2.56
A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am J Clin Pathol (1989) 2.48
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci U S A (1991) 2.40
Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol (1991) 2.37
Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol (1988) 2.37
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science (1993) 2.28
Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer (1990) 2.28
Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med (1991) 2.20
Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol (1990) 2.18
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol (1992) 2.14
Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis (1989) 1.99
Detection of a second widespread strain of Epstein-Barr virus. Lancet (1989) 1.93
Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci U S A (1990) 1.90
Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet (1990) 1.88
Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood (1993) 1.82
When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol (1991) 1.70
Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol (1991) 1.65
Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood (1993) 1.63
In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am J Pathol (1989) 1.60
Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science (1992) 1.58
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57
Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J Virol (1993) 1.55
High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol (1990) 1.54
Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood (1993) 1.54
Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood (1992) 1.51
AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol (1991) 1.45
Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood (1992) 1.45
Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin Exp Immunol (1991) 1.41
Epstein-Barr virus in gastric carcinoma. Am J Pathol (1993) 1.40
Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization. Hum Pathol (1991) 1.38
Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood (1993) 1.35
Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood (1988) 1.34
Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood (1993) 1.33
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood (1991) 1.32
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol (1993) 1.31
CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest (1989) 1.29
Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol (1992) 1.29
Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol (1991) 1.29
Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis (1990) 1.26
Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood (1991) 1.26
Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol (1993) 1.24
Strain variation in Epstein-Barr virus immediate early genes. Virology (1993) 1.23
Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol (1990) 1.21
Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood (1993) 1.16
Oligosaccharide signals: from plant defense to parasite offense. Proc Natl Acad Sci U S A (1994) 1.12
Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease. Am J Pathol (1992) 1.11
Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. Am J Pathol (1992) 1.11
Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes (1993) 1.09
Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J Clin Pathol (1993) 1.08
High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood (1993) 1.06
Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood (1991) 1.05
Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J Virol (1993) 0.99
Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood (1992) 0.99
Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer (1992) 0.97
Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. Am J Pathol (1993) 0.96
Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol (1991) 0.93
Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection. Am J Clin Pathol (1985) 0.92
Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood (1993) 0.92
Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization. Neurology (1989) 0.92
Epstein-Barr virus in Hodgkin disease. Relation to age and subtype. Cancer (1993) 0.92
EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J Virol (1990) 0.90
Prevalence of the A and B types of Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from southern China. J Gen Virol (1992) 0.89
Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br J Cancer (1991) 0.88
Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J Virol (1992) 0.87
Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. Leuk Res (1993) 0.85
Detection of Epstein-Barr virus by in situ hybridization. Progress toward development of a nonisotopic diagnostic test. Am J Pathol (1989) 0.85
Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Mol Cell Probes (1990) 0.84
Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol (1994) 0.84
In situ localization of Epstein-Barr virus in thymic carcinoma. Mod Pathol (1992) 0.83
Non-random integration of Epstein-Barr virus in lymphoblastoid cell lines. Genes Chromosomes Cancer (1993) 0.82
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer (1990) 2.28
Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol (1985) 2.05
Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute. Am J Clin Pathol (1979) 1.84
Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer (1982) 1.77
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer (1984) 1.71
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol (1997) 1.58
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57
Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol (1994) 1.55
Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis (1999) 1.44
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Birds disperse ixodid (Acari: Ixodidae) and Borrelia burgdorferi-infected ticks in Canada. J Med Entomol (2001) 1.26
Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med (1976) 1.21
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol (1985) 1.20
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol (2001) 1.20
Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations. Am J Med (1980) 1.19
Malignant lymphomas involving the prostate. A study of 13 cases. Cancer (1985) 1.18
Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood (1993) 1.16
Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet (1989) 1.11
Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer (1983) 1.09
Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes (1993) 1.09
Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol (1984) 1.06
Immunologic aspects and pathology of the malignant lymphomas. Cancer (1978) 1.06
Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer (1998) 1.03
Interaction of rifampin and warfarin. Chest (1975) 1.03
Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol (1994) 1.02
Evaluation of pathology review of malignant lymphomas and Hodgkin's disease in cooperative clinical trials. The Eastern Cooperative Oncology Group experience. Cancer (1988) 0.95
Alice falls into a black hole: entanglement in noninertial frames. Phys Rev Lett (2005) 0.94
Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer (1982) 0.94
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study. J Clin Oncol (1992) 0.91
Richter's syndrome with two different B-cell clones. Cancer (1986) 0.90
Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia. Am J Clin Pathol (1987) 0.88
Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistry. Hematol Pathol (1995) 0.88
Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. J Natl Cancer Inst (1982) 0.88
What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood (1986) 0.87
Mitotic counts in follicular lymphomas. Hum Pathol (1987) 0.86
High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol (1990) 0.86
Primary lymphomas of the liver. Report of six cases and review of the literature. Am J Clin Pathol (1987) 0.86
Malignant large cell lymphoma of B-cell type with multilobated nuclei. Report of a case and review of the literature. Cancer (1985) 0.86
Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Mol Cell Probes (1990) 0.84
Fatal community-acquired Herellea pneumonia in chronic renal disease. Case report. Am Rev Respir Dis (1973) 0.84
Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol (1994) 0.84
Accessory left atrioventricular connection in type A Wolff-Parkinson-White syndrome. Johns Hopkins Med J (1973) 0.84
Relationship of lysozyme (muramidase) to histiocytic differentiation in malignant histocytosis: an immunohistochemical study. Cancer (1980) 0.84
Localized herpes simplex lymphadenitis. Am J Clin Pathol (1986) 0.83
Histiocytic sarcoma with a granuloma-like component occurring in a large colony of Sprague-Dawley rats. Am J Pathol (1981) 0.83
Uveal involvement in systemic angiotropic large cell lymphoma. Microscopic and immunohistochemical studies. Ophthalmology (1993) 0.83
Unusual manifestation of tuberculosis: TE fistula. Am J Med (1976) 0.81
Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature. Am J Med (1980) 0.81
Immunologic and morphologic studies of T cell lymphoma. Am J Med (1975) 0.81
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma. Leuk Lymphoma (1994) 0.79
Merkel cell (small cell) carcinoma of the skin: immunohistochemical and ultrastructural demonstration of distinctive perinuclear cytokeratin aggregates and a possible association with B cell neoplasms. Histochem J (1986) 0.78
Changes in quantitative SPECT thallium-201 results associated with the use of energy-weighted acquisition. J Nucl Med (1991) 0.78
In situ detection of lytic Epstein-Barr virus infection: expression of the NotI early gene and viral interleukin-10 late gene in clinical specimens. J Infect Dis (1993) 0.78
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma. J Clin Oncol (1987) 0.78
Angioimmunoblastic lymphadenopathy progressing to immunoblastic lymphoma with prominent gastric involvement. Cancer (1982) 0.77
Surface receptors of human neoplastic lymphoreticular cells. Haematol Blood Transfus (1977) 0.77
Immunoblastic sarcoma of the central nervous system in a patient with lymphomatoid granulomatosis. Cancer (1978) 0.77
Primary cutaneous T-cell-rich B-cell lymphoma: clinically distinct from its nodal counterpart? Mod Pathol (2001) 0.76
Stereotactic brain biopsy in the diagnosis of malignant lymphoma. Am J Clin Pathol (1991) 0.76
Splenic hematopoiesis in polycythemia vera. A morphologic and immunohistologic study. Am J Clin Pathol (1988) 0.76
Burkitt's tumour: Lessons from mice, monkeys, and man. Lancet (1977) 0.76
Solitary, isolated metastasis from Ewing's sarcoma to the brain: case report. Surg Neurol (1991) 0.76
Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen. Am J Clin Pathol (1984) 0.76
Blastoid natural killer cell leukemia. Am J Clin Pathol (1999) 0.75
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease. J Clin Oncol (1991) 0.75
Association of Epstein-Barr virus with primary central nervous system lymphoma in AIDS. AIDS Res Hum Retroviruses (1992) 0.75
Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue. Bone Marrow Transplant (1987) 0.75
Three-body dynamics in a (1+1) -dimensional relativistic self-gravitating system. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.75
Molecular detection of bone marrow involvement in intravascular lymphomatosis. Mod Pathol (1997) 0.75
Immunologic markers of non-Hodgkin's lymphomas. Recent Results Cancer Res (1978) 0.75
m-AMSA in refractory lymphoma. A phase II trial of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1985) 0.75
A comparison between the Rappaport Classification and Working Formulation in cooperative group trials: the ECOG experience. Hematol Pathol (1992) 0.75
Mass, action, and entropy of Taub-Bolt-de Sitter spacetimes. Phys Rev Lett (2003) 0.75
Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma. Cancer Treat Rep (1986) 0.75
Chaos in an exact relativistic three-body self-gravitating system. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.75
Radiative electroweak symmetry breaking revisited. Phys Rev Lett (2003) 0.75
Soliton solutions to the einstein equations in five dimensions. Phys Rev Lett (2006) 0.75
Epstein-Bar virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype. Mod Pathol (1995) 0.75
Clinical conferences at the Johns Hopkins Hospital. Clinical-pathological conference. Johns Hopkins Med J (1975) 0.75
Chaos in a relativistic 3-body self-gravitating system. Phys Rev Lett (2003) 0.75
Kaposi's sarcoma with bone marrow involvement: occurrence in a patient with the acquired immunodeficiency syndrome. Am J Med Sci (1986) 0.75
HR can help correct 'behavior mismatch'. Healthc Hum Resour (1994) 0.75
Disseminated histoplasmosis causing reversible gaze palsy and optic neuropathy. J Neuroophthalmol (1999) 0.75